PE Tech Report


Like this article?

Sign up to our free newsletter

Nordic Capital’s The Binding Site appoints chairperson

The Binding Site, a specialist in protein diagnostics and a portfolio company of Nordic Capital, has appointed Mark Stevenson as its new non-executive Chairperson. 

As the former Executive Vice President and Chief Operating Officer of Thermo Fisher Scientific Inc, Stevenson will be able to draw on his extensive experience within the diagnostics and life science tools industries to support The Binding Site’s continued growth and expansion.
Thermo Fisher Scientific Inc, is a Fortune 100 company with over $40 billion in sales and a world leader in serving science through its life science solutions, analytical instruments, specialty diagnostics and laboratory products and biopharma services divisions. Stevenson joined the company executive vice president and president of life sciences solutions through the acquisition of Life Technologies. 

Stevenson has also previously served as president and chief operating officer of life technologies, and president and chief operating officer of Applied Biosystems prior to its merger with Invitrogen Corporation. He currently serves on the board of Ingersoll Rand Inc. (NYSE: IR) and the Personalised Medicine Coalition (PMC) in Washington DC representing innovators, scientists, patients, providers and payers, promoting the understanding and adoption of personalised medicine concepts.

Like this article? Sign up to our free newsletter